Top compounds associated with response to TRABD2B


Feature Type Standardized
Nominal ANOVA
mRNA CD-1530 CTRPv2 pan-cancer AAC 0.091 0.03
mRNA paclitaxel CCLE pan-cancer AAC -0.11 0.03
mRNA nakiterpiosin CTRPv2 pan-cancer AAC 0.075 0.03
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.083 0.04
mRNA JQ-1 CTRPv2 pan-cancer AAC 0.069 0.04
mRNA erismodegib CTRPv2 pan-cancer AAC 0.08 0.05
mRNA JQ-1:MK-0752 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.07 0.05
mRNA YK 4-279 CTRPv2 pan-cancer AAC 0.065 0.05
mRNA Crizotinib CCLE pan-cancer AAC -0.094 0.06
mRNA GW843682X CTRPv2 pan-cancer AAC 0.07 0.06
Download CSV